The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of cabazitaxel in patients with metastatic or inoperable locally advanced dedifferentiated liposarcoma: European Organization for Research and Treatment of Cancer (EORTC) Phase II trial 1202.
 
Roberta Sanfilippo
Honoraria - Lilly; PharmaMar
Consulting or Advisory Role - Lilly
Research Funding - Amgen/Dompé (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst)
 
Richard L Hayward
No Relationships to Disclose
 
Jammbe Musoro
No Relationships to Disclose
 
Charlotte Benson
No Relationships to Disclose
 
Michael Gordon Leahy
No Relationships to Disclose
 
Antonella Brunello
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Ipsen; PharmaMar; Takeda
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Pharmamar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Neeltje Steeghs
Research Funding - AB Science (Inst); Abbvie (Inst); Actuate Therapeutics (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cytovation (Inst); Deciphera (Inst); Genentech (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte (Inst); InteRNA (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst)
 
Ingrid M.E. Desar
No Relationships to Disclose
 
Nasim Ali
No Relationships to Disclose
 
Alice Hervieu
No Relationships to Disclose
 
Khin Thway
No Relationships to Disclose
 
Sandrine Marreaud
No Relationships to Disclose
 
Saskia Litiere
No Relationships to Disclose
 
Hans Gelderblom
Patents, Royalties, Other Intellectual Property - Amgen, Boehringer-Ingelheim, Pfizer, Novartis, Pharmamar, Daiichi, Five Prime (Inst)